Rhythm Pharmaceuticals, Inc. RYTM Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $54.3M-39.1% | $89.14M+48.4% | $60.08M-52.9% | $127.68M+115% | ||
| $334.65M+44.6% | $231.43M+7.3% | $215.77M+4.9% | $205.61M-12.7% | ||
| $103.06M+47.0% | $70.11M+36.5% | $51.36M+324% | $12.12M+518% | ||
| $86.05M+61.9% | $53.14M+89.4% | $28.05M— | —— | ||
| $466.92M+24.8% | $374.2M+21.4% | $308.27M-13.0% | $354.24M+14.9% | ||
| $1.1M+74.7% | $632K-52.9% | $1.34M-39.0% | $2.2M-21.9% | ||
| $5.32M-13.8% | $6.17M-12.2% | $7.03M-10.8% | $7.88M+69.2% | ||
| $480.2M+22.4% | $392.27M+17.9% | $332.75M-13.0% | $382.48M+16.1% | ||
| $13.95M+13.1% | $12.33M+152% | $4.89M+1.8% | $4.8M-16.4% | ||
| $194K-84.9% | $1.29M0.0% | $1.29M-98.3% | $75.81M+983% | ||
| $7.3M+373% | $1.54M— | —— | —— | ||
| $105.94M-8.3% | $115.52M+109% | $55.2M+38.7% | $39.81M-8.3% | ||
| $100.89M-6.8% | $108.27M+2.0% | $106.14M— | —— | ||
| $210.17M-7.7% | $227.72M+39.7% | $162.99M+37.9% | $118.22M+161% | ||
| 120M+196,621% | 61K+3.4% | 59K+5.4% | 56K+12.0% | ||
| -$1.35B-17.0% | -$1.16B-29.1% | -$894.74M-26.0% | -$710.06M-34.2% | ||
| $139.07M+540% | $21.73M-87.2% | $169.76M-35.8% | $264.26M-7.0% | ||
| $480.2M+22.4% | $392.27M+17.9% | $332.75M-13.0% | $382.48M+16.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rhythm Pharmaceuticals, Inc.'s total assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) holds $442.3M in total assets, up 14.4% year over year.
- How much debt does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. carries $112.3M in total debt against $122.9M of shareholders' equity, a debt-to-equity ratio of 0.91.
- How much cash does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. holds $62.1M in cash and equivalents.
- Can Rhythm Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 4.17 — current assets exceed current liabilities.
- Where does Rhythm Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
